#EMCURE
Generik İlaç Settlement: 2009–2019 Arasında Ödeme Alabilirsiniz

2009–2019 arasında Amerika’da reçeteli generik ilaç aldıysanız, bunu kontrol edin. Para almaya hak kazanabilirsiniz. 💵 ABD’de generik ilaç fiyatlarının yapay şekilde yükseltildiği iddiasıyla yürütülen davalarda Glenmark, Lannett,…
Generik İlaç Settlement: 2009–2019 Arasında Ödeme Alabilirsiniz
2009–2019 arasında Amerika’da reçeteli generik ilaç aldıysanız, bunu kontrol edin. Para almaya hak kazanabilirsiniz. 💵 ABD’de generik ilaç fiyatlarının yapay şekilde yükseltildiği iddiasıyla yürütülen davalarda Glenmark, Lannett, Bausch, Apotex, Heritage ve Emcure ile yapılan settlement’ların toplamı yaklaşık $96.5 milyona ulaştı. Şimdi bu paranın bir bölümünün uygun tüketicilere dağıtılması için claim süreci açıldı. Ama önemli: Her generik ilaç kapsamda değil. 👉 Resmi listede bulunan belirli generik reçeteli ilaçlardan birini 👉 1 Mayıs 2009 – 31 Aralık 2019 arasında ABD’de satın aldıysanız 👉 ödeme almaya hak kazanabilirsiniz. Listede farklı hastalıklar için kullanılan çok sayıda ilaç bulunuyor; antibiyotiklerden antidepresanlara, doğum kontrol ilaçlarından diyabet, epilepsi ve diğer hastalıklarda kullanılan ilaçlara kadar geniş bir grup söz konusu.
alaturka.com
September 25, 2026 at 5:59 PM
Stocks to buy: What’s the outlook for Nifty for September 15-September 18 week? Check list of top stock recommendations mybhola.com/stocks-to-bu... #us #uk
Stocks to buy: What's the outlook for Nifty for September 15-September 18 week? Check list of top stock recommendations - fox 40 news in sacramento
Stock market recommendations: Emcure Pharmaceuticals, and VA Tech Wabag are the top stocks to buy on September 15, 2026, recommends Sudeep Shah, Head -
mybhola.com
September 14, 2026 at 4:46 PM
BTST / STBT WATCHLIST · 04 SEPTEMBER 2026 FRIDAY

BTST: Pfocus, Nuvoco, Wockpharma, Emcure

For learning only, not a recommendation.

#PFOCUS #NUVOCO #WOCKPHARMA #EMCURE #BTST
September 4, 2026 at 9:50 AM
▲ NSE:EMCURE Emcure Pharmaceuticals: Revenue up 22.8% YoY, PAT up 36.2% YoY, with international business now 58% of revenue mix. EBITDA margin expanded 50 bps YoY [BULLISH]
August 6, 2026 at 4:15 PM
📊 Daily India Market Intelligence — Aug 6
50 filings · 13 HIGH · 37 MEDIUM

The August 6, 2026, filing batch reveals a market characterized by robust revenue growth in several sectors, notably pharmaceuticals (Emcure, Divi's, Sun Pharma), specialty chemic...

#IndiaMarkets #BSE #NSE

🧵 See Thread ↓
August 6, 2026 at 4:15 PM
MERCK HAS ENTERED NON-EXCLUSIVE LICENSING DEALS WITH AUROBINDO, CIPLA, EMCURE, AND VIATRIS FOR ALIMATRAVIR.
July 24, 2026 at 10:47 AM
ICMR licenses three indigenous medical technologies to Indian pharma firms for cancer and vaccine solutions

ICMR has licensed three indigenous biomedical technologies to Emcure and Biological E for cancer and typhoid solutions. SHetA2 targets HPV-related cervical cancer while two next-gen vaccines…
ICMR licenses three indigenous medical technologies to Indian pharma firms for cancer and vaccine solutions
ICMR has licensed three indigenous biomedical technologies to Emcure and Biological E for cancer and typhoid solutions. SHetA2 targets HPV-related cervical cancer while two next-gen vaccines fight enteric infections. These transfers align with India’s 2026 health innovation push.
news-area.com
July 22, 2026 at 2:28 AM
⚠️ NSE:EMCURE Emcure Pharmaceuticals/Gennova: The acquisition of Gennova at a valuation of ~₹1,924 Cr (implied) for a subsidiary with a net profit margin of ~1.1% and near-flat turnover growth (1.9% in FY25) raises concerns about overpayment and integration ris...
July 13, 2026 at 3:54 PM
Emcure Pharmaceuticals Limited — Merger/Acquisition

Emcure Pharmaceuticals subsidiary Marcan Pharmaceuticals Inc. acquired all Class E Special Shares of Mantra Pharma Inc.

🧵 continued ↓
July 3, 2026 at 5:31 AM
Emcure Viropil Price in India | International Wholesale Supplier - Oddway

#viropiltabletprice #viropilCost #viropiltabletExporterUSA

www.oddwayinternational.com/viropil-tabl...
June 23, 2026 at 9:13 AM
▲ NSE:EMCURE Emcure Pharmaceuticals: FY26 revenue grew 16.6% YoY to ₹9,204 Cr, with ROCE improving 180 bps to 23.8%. Chronic share increased from 26.3% to 38.3% (FY20 vs FY26), indicating a high-quality revenue mix shift. [BULLISH]
June 12, 2026 at 7:46 AM
📊 Mid-Market Digest — Jun 12
50 filings · 6 HIGH · 44 MEDIUM

The mid-day digest reveals a market characterized by strong operational performances in select mid-cap names like Emcure Pharmaceuticals and Airfloa Rail Technology, c...

#Finance #FinancialDisclosure #MarketIntelligence

🧵 See Thread ↓
June 12, 2026 at 7:46 AM
Emcure Viropil Price in India | International Wholesale Supplier - Oddway

#viropiltabletprice #viropilCost #viropiltabletExporterUSA

www.oddwayinternational.com/viropil-tabl...
June 11, 2026 at 10:44 AM
Feed: "The Raisina Hills"
Published on Tuesday, April 21, 2026
Namita Thapar Hits Back: ‘Silence Is Not a Virtue, God Is Watching’
Emcure Pharmaceuticals Executive Director and Shark Tank India judge Namita Thapar fires back at weeks of online abuse.
theraisinahills.com
April 21, 2026 at 12:02 PM
Emcure ED Namita Thapar has hit back at weeks of vicious online abuse over her Namaz health-benefits video — calling it "selective outrage" and warning trolls: "God is watching."

Full story ✍️S. JHA

#NamitaThapar #Emcure #Trolling #SocialMedia #HealthBenefits 👇
theraisinahills.com/namita-thapa...
Namita Thapar Hits Back: ‘Silence Is Not a Virtue, God Is Watching’ - The Raisina Hills
Emcure Pharmaceuticals Executive Director and Shark Tank India judge Namita Thapar fires back at weeks of online abuse.
theraisinahills.com
April 21, 2026 at 8:21 AM